Intramural NIGMS Postdoctoral Research Associate (PRAT) Program (Fi2)

PAR-16-130
Intramural NIGMS Postdoctoral Research Associate (PRAT) Program (Fi2)
Department of Health and Human Services
National Institutes of Health

Section I. Funding Opportunity Descriptionresearch-funding-process

The overall goal of the Intramural NIGMS Postdoctoral Research Associate (PRAT) program is to help ensure that a diverse pool of highly trained scientists is available in appropriate scientific disciplines to address the Nation’s biomedical research needs. The NIGMS PRAT Program can be found at the website http://www.nigms.nih.gov/Training/Pages/PRAT.aspx. In 1965, the first cohort of postdoctoral fellows entered the NIGMS PRAT Program to begin a period of research training in the NIH Intramural Research Program.  Since this time, numerous PRAT alumni have become leaders in their respective fields and across multiple career sectors.  Although this program grew out of a desire to train more individuals in the field of pharmacology, the program has broadened over time and now supports all research areas within the mission of NIGMS.  In 2012, the name of the program was changed to the Postdoctoral Research Associate (PRAT) Program in recognition of the diversity of disciplines supported by the program, but the core features of the program remain the same.  The NIGMS PRAT Program continues to provide access to excellent research, mentoring, and career development resources in the NIH Intramural Research Program and maintains a focus on training leaders in the basic biomedical sciences.

The NIGMS PRAT Program’s overarching goal is to provide high-quality research training in the basic biomedical sciences, in NIH intramural research laboratories, to a diverse group of postdoctoral fellows to prepare them for leadership positions in biomedical careers. This training includes a mentored laboratory experience as well as intensive career and leadership development activities.  Fellows selected for the NIGMS PRAT Program will receive three years of support from this mechanism.

The NIGMS PRAT Program will support fellowship training within the NIH Intramural Research Program that is focused on NIGMS mission-related areas of basic biomedical science. These include but are not limited to cell biology, biophysics, genetics, developmental biology, pharmacology, physiology, biological chemistry, computational biology, technology development and bioinformatics. Studies employing model organisms are encouraged.  Fellows can conduct this work in any of the NIH Institutes or Centers with an Intramural Research Program, with mentors who have relevant experience in these areas of research.  This arrangement allows fellows from a wide array of diverse scientific disciplines to interact on a regular basis and to exchange ideas.

The NIGMS PRAT program distinguishes itself from other postdoctoral training opportunities on the NIH campus through its approach to cultivating the next generation of leaders in the basic biomedical sciences.  Fellows selected for this program are from a wide array of basic biomedical research disciplines.  The fellows interact on a regular basis to present their research and exchange ideas during a monthly seminar series combining a research presentation from a current PRAT fellow with a presentation from an outside speaker.  This communication across disciplines fosters discussion of new research approaches and a deeper appreciation of the contributions these diverse disciplines make to the basic biomedical research enterprise.  The program further broadens the experience of participating fellows by providing intensive mentoring and defined career development activities focused on topics such as leadership skills, oral presentations, and grant-writing as part of the training curriculum.   Fellows selected for the PRAT program are required to participate in the PRAT-sponsored training activities.  The PRAT Program Director(s) oversees all activities of the NIGMS PRAT Program and provides additional mentoring to PRAT fellows.

NIGMS PRAT fellows are encouraged to broaden their training by attending scientific seminars on the NIH campus, traveling to scientific meetings, participating actively in lab meetings, making scientific presentations and publishing the results of their research. Fellows receive formal training in the ethical conduct of research and scientific methods, including a focus on the reproducibility of data. All fellows are strongly encouraged to take courses in quantitative biology and statistics, if they have not already done so. Fellows are exposed broadly to the cutting-edge technologies for which the intramural program is noted.

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-16-130
Funding Opportunity Title: Intramural NIGMS Postdoctoral Research Associate (PRAT) Program (Fi2)
Opportunity Category: Discretionary
Opportunity Category Explanation:  
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:  
Expected Number of Awards:  
CFDA Number(s): 93.859 — Biomedical Research and Research Training
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Sep 07, 2016
Last Updated Date: Sep 07, 2016
Original Closing Date for Applications: Oct 03, 2018  
Current Closing Date for Applications: Oct 03, 2018  
Archive Date: Nov 03, 2018
Estimated Total Program Funding:  
Award Ceiling:  
Award Floor:

Eligibility

Eligible Applicants: State governments
City or township governments
County governments
Special district governments
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The NIGMS Postdoctoral Research Associate (PRAT) Programs overarching goal is to provide high quality postdoctoral research training in the basic biomedical sciences, in NIH intramural research laboratories, to a diverse group of postdoctoral fellows to prepare them for leadership positions in biomedical careers. The research projects proposed should focus on NIGMS mission-related areas of basic biomedical science. These include cell biology, biophysics, genetics, developmental biology, pharmacology, physiology, biological chemistry, computational biology, technology development and bioinformatics. Studies employing model organisms are encouraged.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-16-130.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster FBOWebmaster@OD.NIH.GOV

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

Six Research Grants are Available from NORD for the Study of Rare Diseases

Reminder: Six Research Grants are Available from NORD for the Study of Rare Diseases

pic

These grants are made possible by donations to NORD. In some cases, the grants are co-sponsored by NORD and disease-specific patient organizations. NORD encourages all U.S. and international researchers interested in studying these diseases to consider applying.

  • Alveolar Capillary Dysplasia with Misalignment of the Pulmonary Veins – One (1) grant of up to $50,000, for scientific and/or clinical research studies related to Alveolar Capillary Dysplasia (ACD/MPV). See full RFP and abstract template here.
  • Appendix Cancer and Pseudomyxoma Peritonei – Two (2) grants of up to $50,000 for scientific and/or clinical research studies related to Appendix Cancer and/or Pseudomyxoma Peritonei (PMP). See full RFP and abstract template here.
  • Autoimmune Polyglandular Syndrome Type 1 – One (1) grant of up to $100,000 for scientific and/or clinical research studies related to Autoimmune Polyglandular Syndrome Type 1 (APS Type 1). See full RFP and abstract template here.
  • Homocystinuria – One (1) grant of up to $30,000 for scientific and/or clinical research studies related to Homocystinuria due to Cystathionine Beta-Synthase Deficiency. See full RFP and abstract template here.
  • Malonic Aciduria – One (1) grant of up to $30,000 for scientific and/or clinical research studies related to Malonic Aciduria. See full RFP and abstract template here.
  • Stiff Person Syndrome – One (1) grant of up to $30,000 for scientific and/or clinical research studies related to Stiff Person Syndrome. See full RFP and abstract template here.

For more information about NORD’s research grant program and rare disease research funding opportunities, visit: http://rarediseases.org/requests-proposals.

“High” or “Medium” Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R21)

PA-16-425
“High” or “Medium” Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R21)
Department of Health and Human

Print Services
National Institutes of Health

Section I. Funding Opportunity Description
Purpose

The purpose of this funding opportunity announcement (FOA) is to continue advancing our understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying human immunodeficiency (HIV) infection or acquired immunodeficiency syndrome (AIDS), particularly the non-AIDS defining malignancies which are now a leading cause of death in HIV-infected individuals.

This FOA encourages high or medium priority AIDS research in areas such as the study of the etiologic factors, cofactors, immunopathogenesis, diagnosis, and consequences of both non-AIDS defining and AIDS-defining malignancies in populations with an underlying HIV infection.

This FOA encourages research efforts that will (i) identify specific contributions resulting from HIV infection and its potential interaction with other pathogens for the development and pathogenesis of these cancers and (ii) provide information on the clinical outcomes of such cancers in the HIV-infected population.

Ultimately, such efforts could inform screening approaches and therapies targeted to the HIV-infected population.

This FOA utilizes the Exploratory/Developmental Grant (R21) mechanism, which supports investigation of novel scientific ideas or new model systems, tools, or technologies that have the potential for significant impact on biomedical or biobehavioral research. An R21 grant application need not have extensive background material or preliminary information.

This FOA runs in parallel with another FOA of identical scientific scope, PA-16-426, which utilizes the Exploratory/Developmental Grant (R01) mechanism.

Scope

In 2015, NIH and OAR mandated that in the future, AIDS funds can only be used in for research addressing “high” or “medium” priority areas of AIDS research as defined in NOT-OD-15-137“NIH HIV/AIDS Research Priorities and Guidelines for Determining AIDS Funding”.

Topics considered “low priority” AIDS in NOT-OD-15-137 are not appropriate for this PAR except basic research in tumors caused by KSHV has, for the moment, been considered as “high priority” AIDS and will be eligible for funding under this PAR.  All applications considered for funding will be reviewed by OAR and must be aligned with the priorities in NOT-OD-15-137.

Specific areas of study in the indicated categories may include, but are not limited to, the following examples:

A) Biomarkers, Diagnostics, and Therapeutics:

  • Discovery of reliable molecular and immunological diagnostic and prognostic biomarkers and pathogen markers, useful for early detection, progression, or response to treatment of non-AIDS-defining and AIDS-defining malignancies;
  • Discovery and development of novel targets and efficacious new therapeutic agents, interventional strategies, or improved delivery systems for the treatment of cancer in people with HIV infection, however clinical trials are not permitted;
  • Studies to understand the pharmacokinetics of targeted therapies for AIDS-defining and non-AIDS defining malignancies in the context of highly active antiretroviral therapy and;
  • Studies utilizing existing cohorts and tissue banks of human specimens from a wide spectrum of AIDS-defining and non-AIDS defining malignancies to develop biomarker, diagnostic assays, or analyze samples and data acquired from these cohorts is encouraged. Examples of such cohorts and repositories include:
  • AIDS and Cancer Specimen Resource (ACSR),
  • Women’s Interagency HIV Study (WIHS)),
  • Veterans Aging Cohort Study (VACS)
  • Multicenter AIDS Cohort Study (MACS).

Investigators are also encouraged to utilize infrastructure support of the Centers for AIDS Research (CFAR) or NCI designated Cancer Centers if located at those institutions.

However, descriptive research and recruitment or retention of cohorts are not appropriate for this FOA.

General Information

Document Type: Grants Notice
Funding Opportunity Number: PA-16-425
Funding Opportunity Title: “High” or “Medium” Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R21)
Opportunity Category: Discretionary
Opportunity Category Explanation:  
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:  
Expected Number of Awards:  
CFDA Number(s): 93.121 — Oral Diseases and Disorders Research
93.393 — Cancer Cause and Prevention Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Sep 07, 2016
Last Updated Date: Sep 07, 2016
Original Closing Date for Applications: Sep 07, 2019  
Current Closing Date for Applications: Sep 07, 2019  
Archive Date: Oct 08, 2019
Estimated Total Program Funding:  
Award Ceiling: $200,000
Award Floor:

Eligibility

Eligible Applicants: Special district governments
Small businesses
Native American tribal organizations (other than Federally recognized tribal governments)
Public and State controlled institutions of higher education
County governments
Independent school districts
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Public housing authorities/Indian housing authorities
State governments
City or township governments
Native American tribal governments (Federally recognized)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this funding opportunity announcement (FOA) is to continue advancing our understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying human immunodeficiency (HIV) infection or acquired immunodeficiency syndrome (AIDS), particularly the non-AIDS defining malignancies which are now a leading cause of death in HIV-infected individuals. This FOA encourages high or medium priority AIDS research in areas such as the study of the etiologic factors, cofactors, immunopathogenesis, diagnosis, and consequences of both non-AIDS defining and AIDS-defining malignancies in populations with an underlying HIV infection.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PA-16-425.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster FBOWebmaster@OD.NIH.GOV

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

Federal prize competition seeks innovative ideas to combat antimicrobial resistance

Source: https://www.nih.gov/news-events/news-releases/federal-prize-competition-seeks-innovative-ideas-combat-antimicrobial-resistance

Contestants will vie for $20 million in prizes to develop new innovative laboratory diagnostic tools that detect and distinguish antibiotic resistant bacteria.

A federal prize competition launched today is calling for innovative ideas for rapid, point-of-care laboratory diagnostic tests to combat the development and spread of drug resistant bacteria, a rising public health threat. Antibiotic resistant bacteria cause at least 2 million infections and 23,000 deaths each year in the United States, according to the Centers for Disease Control and Prevention.

The Antimicrobial Resistance Diagnostic Challenge will award $20 million in prizes over all phases of the competition for new, innovative and novel laboratory diagnostic tests. The diagnostic tests being sought are those that identify and characterize antibiotic resistant bacteria and those that distinguish between viral and bacterial infections to reduce unnecessary uses of antibiotics, a major cause of drug resistance. The prize is sponsored by two U.S. Department of Health and Human Services components, the National Institutes of Health and the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR) in support of the National Action Plan for Combating Antibiotic Resistant Bacteria(link is external).

“The growing incidence of serious infections from antibiotic resistant bacteria presents a critical risk to the public health of our nation,” said NIH Director Francis S. Collins, M.D., Ph.D. “My hope is that this competition will spur exceptional innovators to rise to the challenge and deliver effective tools to help manage this significant problem.”Scanning electron micrograph of neutrophil ingesting methicillin-  resistant Staphylococcus aureus bacteria.

With real-time detection, healthcare providers would be able to identify infecting pathogens and resistance factors within hours, rather than the two to three days or longer that the standard microbiological culture processes require. Such knowledge would allow tailoring of treatments, minimizing the broad-spectrum antibiotic approach used by many clinicians today.

“This effort even goes beyond public health,” said Nicole Lurie, M.D., M.S.P.H., assistant secretary for preparedness and response. “Combating antibiotic-resistant bacteria is a priority issue for economic and national security.”

Concepts must be submitted by Jan. 9, 2017, for the first phase of the competition. Up to 20 semi-finalists will be selected from the applicant pool, each receiving up to $50,000. In the second phase of the competition, on Dec. 3, 2018, up to 10 finalists will be selected to each receive up to $100,000.  These funds can be used to develop prototypes for evaluation by two CLIA(link is external)-certified independent laboratories, which will be considered when final winners are selected. In the final phase, winners are expected to be announced on July 31, 2020.  The competition specifies that up to three winners can be selected, and winners will share an amount equal to or greater than $18 million.

NIH’s National Institute of Allergy and Infectious Diseases and ASPR’s Biomedical Advanced Research and Development Authority (BARDA) each contributed $10 million to the challenge. The CDC and the U.S. Food and Drug Administration provided technical and regulatory expertise to the design of the challenge competition. Technical criteria, objectives and performance characteristics of laboratory diagnostics that would be considered for the prize were informed by stakeholder input from a public workshop and a request for information.  For more information about the challenge or how to apply, please visit the challenge website(link is external).

About the Biomedical Advanced Research and Development Authority (BARDA): BARDA, within the HHS Office of the Assistant Secretary for Preparedness and Response, provides an integrated, systematic approach to the development and purchase of the necessary vaccines, drugs, therapies, and diagnostic tools for public health medical emergencies. For more information about BARDA, visit www.phe.gov/about/BARDA/Pages/default.aspx(link is external).

About the Office of the Assistant Secretary for Preparedness and Response (ASPR): ASPR leads HHS in preparing the nation to respond to and recover from adverse health effects of emergencies, supporting communities’ ability to withstand adversity, strengthening health and response systems, and enhancing national health security. For more information about ASPR and for expertise, tools, and resources to help your community prepare, respond and recover from public health emergencies, visitwww.phe.gov(link is external).

About the National Institute of Allergy and Infectious Diseases (NIAID): NIAID conducts and supports research — at NIH, throughout the United States, and worldwide — to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.

About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

ADVANCE: Increasing the Participation and Advancement of Women in Academic Science and Engineering Careers

16-594
ADVANCE: Increasing the Participation and Advancement of Women in Academic Science and Engineering Careers
National Science FoundationWISE

General Information

Document Type: Grants Notice
Funding Opportunity Number: 16-594
Funding Opportunity Title: ADVANCE: Increasing the Participation and Advancement of Women in Academic Science and Engineering Careers
Opportunity Category: Discretionary
Opportunity Category Explanation:  
Funding Instrument Type: Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:  
Expected Number of Awards: 26
CFDA Number(s): 47.041 — Engineering Grants
47.049 — Mathematical and Physical Sciences
47.050 — Geosciences
47.070 — Computer and Information Science and Engineering
47.074 — Biological Sciences
47.075 — Social, Behavioral, and Economic Sciences
47.076 — Education and Human Resources
47.079 — Office of International Science and Engineering
47.083 — Office of Integrative Activities
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Aug 27, 2016
Last Updated Date: Aug 27, 2016
Original Closing Date for Applications: Jan 11, 2017  Adaptation Letter of Intent; Adaptation full proposal; Partnerships Letter of Intent; Partnerships Full Proposal; Institutional Transformation Preliminary Proposal; Institutional Transformation full proposal
Current Closing Date for Applications: Jan 11, 2017  Adaptation Letter of Intent; Adaptation full proposal; Partnerships Letter of Intent; Partnerships Full Proposal; Institutional Transformation Preliminary Proposal; Institutional Transformation full proposal
Archive Date: Feb 18, 2022
Estimated Total Program Funding: $22,200,000
Award Ceiling: $3,000,000
Award Floor: $1,000,000

 
Additional Information

Agency Name: National Science Foundation
Description: Despite significant increases in the proportion of women pursuing science, technology, engineering, and mathematics (STEM) doctoral degrees, women are significantly underrepresented as faculty, particularly in upper ranks, and in academic administrative positions, in almost all STEM fields.  The problems of recruitment, retention, and advancement that are the causes of this underrepresentation vary by discipline and across groups of women faculty (e.g., by race/ethnicity, disability status, sexual orientation, foreign-born and foreign-trained status, and faculty appointment type).  The ADVANCE program is designed to foster gender equity through a focus on the identification and elimination of organizational barriers that impede the full participation and advancement of all women faculty in academic institutions.  Organizational barriers that inhibit equity may exist in areas such as policy, practice, culture, and organizational climate.  For example, practices in academic departments that result in the inequitable allocation of service or teaching assignments may impede research productivity, delay advancement and create a culture of differential treatment and rewards.  Policies and procedures that do not mitigate implicit bias in hiring, tenure, and promotion decisions could mean that women and underrepresented minorities are evaluated less favorably, perpetuating their underrepresentation and contributing to a climate that is not inclusive.     The goals of the ADVANCE program are (1) to develop systemic approaches to increase the representation and advancement of women in academic STEM, [1] careers; (2) to develop innovative and sustainable ways to promote gender equity that involve both men and women in the STEM academic workforce; and (3) to contribute to the research knowledge base on gender equity and the intersection of gender and other identities in STEM academic careers.  The ADVANCE program contributes to the development of a more diverse science and engineering workforce because of the focus on equity for STEM academic faculty who are educating, training, and mentoring undergraduate and graduate students and postdoctoral scholars.  There are three program tracks.  All projects are expected to build on prior ADVANCE work and gender equity research and literature to broaden the implementation of organizational and systemic strategies to foster gender equity in STEM academic careers.  All ADVANCE proposals are expected to recognize that gender does not exist in isolation from other characteristics, such as race/ethnicity, disability status, sexual orientation, foreign-born and foreign-trained status, faculty appointment type, etc., and should offer strategies to promote gender equity for all faculty: The Institutional Transformation (IT) track supports the development of innovative organizational change strategies to produce comprehensive change within one non-profit two-year or four-year academic institution across all STEM disciplines.  IT projects are also expected to contribute new research on gender equity in STEM academics.  Projects that do not propose innovative strategies may be more appropriate for the Adaptation track.

The Adaptation track supports the adaptation and implementation of evidence-based organizational change strategies, ideally from among those developed and implemented by ADVANCE projects.  Adaptation awards may support the adaptation and implementation of proven organizational change strategies within a non-profit two-year or four-year academic institution that has not had an ADVANCE IT award.  Adaptation awards may also be made to a STEM organization to implement systemic change strategies focused across all STEM disciplines, several STEM disciplines, or within one STEM discipline.  The Partnership track will support partnerships of two or more non-profit academic institutions and/or STEM organizations to increase gender equity in STEM academics.  Projects should have national or regional impact and result in systemic change within one STEM discipline, several STEM disciplines, or all STEM disciplines.  Partnering STEM organizations can include any entity eligible for NSF support.  Partners may include professional societies, industry, non-profit organizations, publishers, policy and research entities, state systems of higher education, higher education organizations, as well as institutions of higher education.  Partnership proposals must include a final year focused on sustainability and/or scale-up, communication, and evaluation. For all proposals, ADVANCE is interested in supporting a range of non-profit academic institution types including: community colleges, primarily undergraduate institutions, minority-serving institutions (e.g. Tribal Colleges and Universities, Historically Black Colleges and Universities, Hispanic-Serving Institutions, Native Hawaiian Serving Institutions, Alaska Native Institutions, Predominantly Black Institutions and Non-tribal, Native American Serving Institutions), women’s colleges, institutions primarily serving persons with disabilities, and master’s and doctoral level institutions. ADVANCE does not provide fellowships, research grants, or travel grants to individual students, postdocs, or faculty.  Undergraduate STEM opportunities can be found at <a href= http://stemundergrads.science.gov and graduate STEM opportunities at = http://stemgradstudents.science.gov

All STEM fields supported by NSF are included in the ADVANCE program.  STEM includes the learning, social, behavioral, and economic sciences.  The program does not include clinical science faculty. </div> </div>

Link to Additional Information: NSF Publication 16-594
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NSF grants.gov support grantsgovsupport@nsf.gov

If you have any problems linking to this funding announcement, please contact

NLM Grants for Scholarly Works in Biomedicine and Health (G13)

PAR-16-417
NLM Grants for Scholarly Works in Biomedicine and Health (G13)
Department of Health and Human Services
National Institutes of Healthbiomedicine

Section I. Funding Opportunity Description

The National Library of Medicine (NLM) awards Grants for Scholarly Works in Biomedicine and Health for the preparation of book-length manuscripts and other works of academic and/or public health policy value to U.S. health professionals, public health officials, biomedical researchers, and historians of the health sciences. Grants are awarded for major critical reviews, state-of-the-art summaries, historical studies, and other useful organizations of knowledge in clinical medicine, public health, biomedical research, and the informatics/information sciences relating to them. The work of academic and/or public health policy value may be prepared for publication in print or electronic media, or both.

Scholars in biomedical fields face competing demands for their time, including requirements for clinical care services, grant-related research and administrative duties. Scholarly work draws upon original sources that may reside in archives, databases, libraries or human experts around the world, in many different languages and formats. The work of scholarship – discovery, thoughtful analysis, synthesis and lucid presentation of findings from such materials – requires protected time and support for incidental costs, including materials, staff assistance, and travel. The NLM Grant for Scholarly Works in Biomedicine and Health is intended to help defray such expenses.

NLM Grants for Scholarly Works can be used to support several types of projects of academic and/or public health policy value, including but not limited to:

  • Works focusing on the history or philosophy of medicine, public health and the life sciences, the development of medical research and health services, bioethics, and studies on the interrelationship of medicine and society
  • Works focusing on the history or philosophy of biomedical informatics, computational biology, health information sciences, health communications, or health sciences librarianship
  • Analytical and comprehensive critical reviews which identify the present status of research and practice in various health-related fields, addressing advances which have been made, problems requiring examination, and emerging trends

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-16-417
Funding Opportunity Title: NLM Grants for Scholarly Works in Biomedicine and Health (G13)
Opportunity Category: Discretionary
Opportunity Category Explanation:  
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:  
Expected Number of Awards:  
CFDA Number(s): 93.879 — Medical Library Assistance
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Aug 26, 2016
Last Updated Date: Aug 26, 2016
Original Closing Date for Applications: Feb 23, 2018  
Current Closing Date for Applications: Feb 23, 2018  
Archive Date: Mar 26, 2018
Estimated Total Program Funding:  
Award Ceiling: $50,000
Award Floor:  

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Others (see text field entitled “Additional Information on Eligibility” for clarification)
City or township governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Small businesses
Native American tribal organizations (other than Federally recognized tribal governments)
County governments
Independent school districts
Private institutions of higher education
For profit organizations other than small businesses
State governments
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Additional Information

Agency Name: National Institutes of Health
Description: NLM Grants for Scholarly Works in Biomedicine and Health are awarded for the preparation of book-length manuscripts and other works of academic and/or public health policy value to U.S. health professionals, public health officials, biomedical researchers and historians of the health sciences.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-16-417.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster FBOWebmaster@OD.NIH.GOV

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

NCI Small Grants Program for Cancer Research (NCI Omnibus R03)

PAR-14-007
NCI Small Grants Program for Cancer Research (NCI Omnibus R03)
Department of Health and Human Services
National Institutes of Healthall-of-us-v-cancer

Section I. Funding Opportunity Description

This funding opportunity announcement (FOA), issued by the National Cancer Institute (NCI) of the National Institutes of Health (NIH), supports discrete, well-defined projects in any area of cancer research using the NIH R03 small grant mechanism.

The NIH R03 small grant mechanism supports discrete, well-defined projects that realistically can be completed in 2 years and that require limited levels of funding. Examples of the types of projects that the R03 grant mechanism include, but are not limited to, the following:

  • Pilot or feasibility studies;
  • Secondary analysis of existing data;
  • Small, self-contained research projects;
  • Development of research methodology; and
  • Development of new research technology.
Specific Research Objectives

All areas of cancer research relevant to the mission of the NCI are appropriate for projects submitted in response to this FOA (for a list of extramural research funding programs at the NCI, go to http://www.cancer.gov/researchandfunding/extramural). Projects proposed in response to this FOA may involve basic, translational, clinical, and/or population research related to cancer. Examples of relevant areas include but are not limited to studies of: cancer biology; cancer control; cancer diagnosis; cancer disparities; cancer prevention; and cancer treatment.

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-14-007
Funding Opportunity Title: NCI Small Grants Program for Cancer Research (NCI Omnibus R03)
Opportunity Category: Discretionary
Opportunity Category Explanation:  
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:  
Expected Number of Awards:  
CFDA Number(s): 93.393 — Cancer Cause and Prevention Research
93.394 — Cancer Detection and Diagnosis Research
93.395 — Cancer Treatment Research
93.396 — Cancer Biology Research
93.399 — Cancer Control
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Nov 21, 2013
Last Updated Date: Aug 26, 2016
Original Closing Date for Applications: Jan 05, 2017  
Current Closing Date for Applications: Aug 26, 2016  
Archive Date: Sep 26, 2016
Estimated Total Program Funding:  
Award Ceiling: $50,000
Award Floor:  

Eligibility

Eligible Applicants: Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
For profit organizations other than small businesses
State governments
Public housing authorities/Indian housing authorities
Special district governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Independent school districts
Public and State controlled institutions of higher education
Private institutions of higher education
City or township governments
Native American tribal governments (Federally recognized)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This funding opportunity announcement (FOA), issued by the National Cancer Institute (NCI), of the National Institutes of Health (NIH) supports small research projects on cancer that can be carried out in a short period of time with limited resources. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-14-007.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster FBOWebmaster@OD.NIH.GOV

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster